Document is current
Any future updates will be listed below
-
Authors
O’Hare, Meabh http://orcid.org/0009-0004-7537-7803
Guidon, Amanda C.
- License Information
-
More Information
Article History
Accepted: 11 July 2024
First Online: 9 August 2024
Competing interests
: A.C.G. declares that she has acted as a consultant and/or medical advisory board member for Argenx, Alexion and UCB (Ra Pharma); receives publishing royalties from Oakstone Publications; and has received research funding from the MGNet Rare Disease Network, MGNet Scholar Award, National Institutes of Health (NIH) Rare Disease Clinical and Research Training Program, Project Data Sphere, Dysimmune Disease Foundation and National Institute of Neurological Disorders and Stroke (NINDS) with Biosensics (grant 1R44NS122672-01A1). M.O’H. declares no competing interests.
